IMA vs MTB · rev $9.2M vs P/E 12, $30.99B cap
ImageneBio, Inc. (IMA) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
MTB does not have a complete income-statement cache yet.
IMA currently screens at market cap $64.7M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the IMA and MTB stock pages for the full models.
Not investment advice.